Joan Carles Contel

Joan Carles Contel

Auto-generated profile, based on publicly available information

Joan Carles Contel

Generalitat de Catalunya

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2016 in International Journal of Integrated Care
Verified
Journal Article
Open access
PDF file
José Joaquin MiraJosé Joaquin Mira
José Joaquin Mira
RNRoberto Nuño-Solinís
Roberto Nuño-Solinís
Mercedes Guilabert MoraMercedes Guilabert Mora
Mercedes Guilabert Mora
OSOlga Solas-Gaspar
Olga Solas-Gaspar
PFPaloma Fernández-Cano
Paloma Fernández-Cano
MRMarío del Río-Cámara
Marío del Río-Cámara
The experience of chronic patients with the care they receive, fuelled by the focus on patient-centeredness and the increasing evidence on its positive relation with other dimensions of quality, is being acknowledged as a key element in improving the quality of care. There are a dearth of accepted tools and metrics to assess patient experience from the patient's perspective that have been adapted to the new chronic care context: continued, systemic, with multidisciplinary teams and new technologies. Development and validation of a scale conducting a literature review, expert panel, pilot and field studies with 356 chronic primary care patients, to assess content and face validities and reliability. IEXPAC is an 11+1 item scale with adequate metric properties measured by Alpha Chronbach, Goodness of fit index, and satisfactory convergence validity around three factors named: productive interactions, new relational model and person's self-management. IEXPAC allows measurement of the patient experience of chronic illness care. Together with other indicators, IEXPAC can determine the quality of care provided according to the Triple Aim framework, facilitating health systems reorientation towards integrated patient-centred care.

SBSergi Blancafort
Sergi Blancafort
CCCésar Cuevas-Lara
César Cuevas-Lara
NMNicolas Martinez-Velilla
Nicolas Martinez-Velilla
FZFabricio Zambom-Ferraresi
Fabricio Zambom-Ferraresi
MSMaria Eugenia Soto
Maria Eugenia Soto
ACAntoni Salvà Casanovas
Antoni Salvà Casanovas
The World Health Organization has developed the Integrated Care of Older People (ICOPE) strategy, a program based on the measurement of intrinsic capacity (IC) as “the composite of all physical and mental attributes on which an individual can draw”. Multicomponent interventions appear to be the most effective approach to enhance IC and to prevent frailty and disability since adapted physical activity is the preventive intervention that has shown the most evidence in the treatment of frailty and risk of falls. Our paper describes the development of a multi-domain group-based intervention addressed to older people living in the community, aimed at improving and/or maintaining intrinsic capacity by means of promoting physical activity, healthy nutrition, and psychological wellbeing in older people. The process of intervention development is described following the Guidance for reporting intervention development studies in health research (GUIDED). The result of this study is the AMICOPE intervention (Aptitude Multi-domain group-based intervention to improve and/or maintain IC in Older PEople) built upon the ICOPE framework and described following the Template for Intervention Description and Replication (TIDieR) guidelines. The intervention consists of 12 face-to-face sessions held weekly for 2.5 h over three months and facilitated by a pair of health and social care professionals. This study represents the first stage of the UK Medical Research Council framework for developing and evaluating a complex intervention. The next step should be carrying out a feasibility study for the AMICOPE intervention and, at a later stage, assessing the effectiveness in a randomized controlled trial.

22 April 2015 in International Journal of Integrated Care
Verified
Journal Article
Open access
PDF file
JCJuan Carlos Contel
Juan Carlos Contel
ALAlbert Ledesma
Albert Ledesma
CBCarles Blay
Carles Blay
AMAssumpció González Mestre
Assumpció González Mestre
CCCarmen Cabezas
Carmen Cabezas
CCCarles Constante
Carles Constante
The Chronicity Prevention and Care Programme set up by the Health Plan for Catalonia 2011-2015 has been an outstanding and excellent opportunity to create a new integrated care model in Catalonia. People with chronic conditions require major changes and transformation within the current health and social system. The new and gradual context of ageing, increase in the number of chronic diseases and the current fragmented system requires this transformation to be implemented. The Chronicity Prevention and Care Programme aims to implement actions which drive the current system towards a new scenario where organisations and professionals must work collaboratively. New tools should facilitate this new context- or work-like integrated health information systems, an integrative financing and commissioning scheme and provide a new approach to virtual care by substituting traditional face-to-face care with transfer and shared responsibilities between patients, citizens and health care professionals. It has been observed some impact reducing the rate of emergency admissions and readmission related to chronic conditions and better outcome related to better chronic disease control. Some initiative like the Catalan Expert Patient Program has obtained good results and an appropriate service utilization. The implementation of a Chronic Care Program show good results but it is expected that the new integrated health and social care agenda could provoke a real change and transformation. Some of the results related to better health outcomes and a decrease in avoidable hospital admissions related to chronic conditions confirm we are on the right track to make our health and social system more sustainable for the decades to come.

SGSebastià Josep Santaeugènia Gonzàlez
Sebastià Josep Santaeugènia Gonzàlez
JCJoan C. Contel
Joan C. Contel
EVEmili Vela
Emili Vela
MCMontserrat Cleries
Montserrat Cleries
PAPaloma Amil
Paloma Amil
JAJordi Amblàs-Novellas
Jordi Amblàs-Novellas
The Chronic Care Program introduced in Catalonia in 2011 focuses on improving the identification and management of complex chronic (CCPs) and advanced chronic patients (ACPs) by implementing an individualized care model. Its first stage is their identification based on chronicity, difficult clinical management (i.e., complexity), and, in ACPs, limited life prognosis. Subsequent stages are individual evaluation and implementation of a shared personalized care plan. This retrospective study, including all CCPs and ACPs identified in Catalonia between 2013 and 2019, was aimed at describing the characteristics and healthcare service utilization among these patients. Data were obtained from an administrative database and included sociodemographic, clinical, and service utilization variables and morbidity-associated risk according to the Adjusted Morbidity Groups (GMA) stratification. During the study period, CCPs’ and ACPs’ prevalence increased and was higher in lower-income populations; most cases were women. CCPs and ACPs had all comorbidities at higher frequencies, higher utilization of healthcare services, and were more frequently at high risk (63% and 71%, respectively) than age-, sex-, and income level-adjusted non-CCP (23%) and non-ACP populations (30%). These results show effective identification of the program’s target population and demonstrate that CCPs and ACPs have a higher burden of multimorbidity and healthcare needs.

Mercedes Guilabert MoraMercedes Guilabert Mora
Mercedes Guilabert Mora
PAPaloma Amil
Paloma Amil
AGAsunción González-Mestre
Asunción González-Mestre
EGEsther Gil-Sánchez
Esther Gil-Sánchez
AVAnna Vila
Anna Vila
José Joaquin MiraJosé Joaquin Mira
José Joaquin Mira
Objective: Design and validate a measure of the experience of family caregivers with the integrated care that receive the persons they care for. Methods: The new instrument for measuring the experience of caregivers is based on the Instrument to Evaluate the EXperience of PAtients with Chronic Diseases (acronym in Spanish: IEXPAC) scale instrument. With the qualitative technique of the discussion group, nine professionals and eight caregivers assessed the face validity of the instrument and they advised on issues to explore and the measuring scale to use. The instrument’s items were analyzed individually, as well as its consistency, reliability, and construct and empirical validity. Results: 235 caregivers responded, of which 186 (79%) were women. The average age of the persons under their care was 83.9 years (SD 9.7). The scale’s score when eliminating its items one by one ranged between 38.6 and 41.1. The factorial saturations of the items ranged between 0.53 and 0.82. Cronbach’s alpha (12 elements) was 0.88 and the Kuder-Richardson coefficient was 0.91. The factorial solution explained 64.3% of the total variance and allowed isolating two factors (with 11 items with saturations greater than 0.65): care for the patient, and care for the caregiver. The internal consistency of both factors was greater than 0.80. The scale’s score was 41.1 (SD 9.7). Conclusions: The Caregivers Experience Instrument combines acceptability, ease of comprehension, and perceived usefulness for the caregivers. It has adequate internal consistency, reliability, and construct and empirical validity.

16 February 2023 in Journal of Medical Internet Research
Verified
Journal Article
Open access
RCRUBEN GONZALEZ COLOM
RUBEN GONZALEZ COLOM
CHCarmen Herranz
Carmen Herranz
EVEmili Vela
Emili Vela
DMDavid Monterde
David Monterde
JCJoan Carles Contel
Joan Carles Contel
ICIsaac Cano
Isaac Cano
The capsular polysaccharide fromCryptococcus neoformans serotype C has been studied using the usual methods for the elucidation of chemical structure. The results are consistent with the occurrence of a polysaccharide having an α 1,3 linked backbone ofd-mannopyranoside residues, every other one of which is doubly substituted with two terminald-xylopyranosyl residues linked β (1,2 and β 1,4 respectively, and with the remainder of the mannosyl residues substituted with a terminald-glucuronosidopyranosyl residue linked β 1,2. Alternatively, the terminal glucuronic acid residue may be β (1,2 linked to a mannosyl residue in the chain already hearing a singly branched β 1,4 xylopyranosyl residue, while the neighboring mannosyl residue carries a single branch of β 1.2 xylopyranoside.